Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2012 Results
Date:5/8/2012

351,618Prepaid expenses, deposits and other current assets2,5642,999Total current assets161,349153,501Marketable securities, non-current-19,012Property and equipment, net2,478964Other assets, non-current8484Intangible asset, net7,6588,027Restricted cash1,0301,030Total assets$

172,599$

182,618LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$

780$

996Accrued liabilities, current5,0933,381Deferred rent, current-453Deferred revenues, current26,78926,789Total current liabilities32,66231,619Non-current liabilities:Accrued liabilities, non-current278-Deferred rent, non-current2,281461Deferred revenues, non-current110,458117,064Total liabilities145,679149,144Stockholders' equity:Common stock2828Additional paid-in capital298,270296,868Accumulated other comprehensive income2721Accumulated deficit(271,405)(263,443)Total stockholders' equity26,92033,474Total liabilities and stockholders' equity$

172,599$

182,618USE OF NON-GAAP FINANCIAL MEASURESTo supplement the financial statements presented in accordance with generally accepted accounting principles, or GAAP, Vanda uses measures of non-GAAP G&A and R&D expenses. A reconciliation of these non-GAAP financial measures to the closest GAAP financial measure, is presented in the financial table below.

2012 Full Year Guidance GAAP to Non-GAAP adjustmentsFull Year 2012 Guidance(in millions)LowHighGeneral & administrative expenses

$
3.0$
5.0G&A Non-cash stock-based compensation

3.03.0Non-GAAP General & administrative expenses

10.012.0Research & development  expenses

42.047.0R&D Non-cash stock-based compensation

2.52.5Non-GAAP Research & development  expenses

$
39.5$
44.5Vanda believes that the non-GAAP financial information provided in this release can assist investors in understanding and assessing the ongoing economics of the company's
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , England , Aug. ... and UK biotechnology company Synairgen plc (LSE: SNG) today announced ... selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) ... IPF affects in the region of 100,000 ... global revenues in excess of $1.1 billion by 2017. The LOXL2 ...
(Date:8/4/2015)... On August 3, 2015, a press conference on ... a donation ceremony of a million masks by Wuhan Longfeixiang ... Beijing . Wuhan Longfeixiang ... of Hubei Longfeixiang Industrial Group, which has successfully developed ... Baihe anti-pollution mask, filling the global gap for masks ...
(Date:8/4/2015)... Ill. , Aug. 4, 2015 ... dental supplies and equipment, today announced the acquisition ... Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD ... used in preventive and restorative dental procedures. ... expansion of our business in attractive, high-growth segments," ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
... STOCKHOLM, May 15, 2012 Medivir AB ... infectious diseases, announced today that it has appointed Henric ... commercial activities. Henric, who will have overall responsibility for ... in August 2012 and will be part of the ...
... May 14, 2012 Top leaders representing America,s ... discuss pressing public policy issues affecting job creation and medical ... than $20 billion medical device tax set to begin in ... and Jim Renacci (R-Ohio) joined Walter M Rosebrough, president and ...
Cached Medicine Technology:New Executive Vice President Commercial Appointed 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 3
(Date:8/4/2015)... ... 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed its list of the ... ranked as the best dating service in the segment. , A representative from the ... essential that people find the right dating platform so that they can make the ...
(Date:8/4/2015)... ... August 05, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting more than 700,000 members and over 200 ...
(Date:8/4/2015)... ... ... NOVA Pride , Northern Virginia’s largest and newest LGBTQ nonprofit organization, invites ... them in paving “The Road Ahead” at the second annual Northern Virginia Pride Festival, ... from 12-9pm. In order to ensure the success of this important event, NOVA Pride ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... How cool ... share what inspires you via geolocation? The new "Now" feature will soon allow you ... will be able to inspire each other using the now feature. , Users will ...
(Date:8/4/2015)... ... August 04, 2015 , ... Statement by Paul Gionfriddo, ... introduction of the Mental Health Reform Act of 2015 by Senators Bill ... health reform a reality in America. , “This legislation and H.R. 2646 ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3
... specialist makes a difference, study finds , WEDNESDAY, Aug. 22 ... to see the doctor who diagnoses their melanoma, the more ... -- skin cancer at the time of diagnosis, a new ... poorer patients getting diagnosed with thicker melanomas, the researchers said. ...
... the brain, study suggests , , WEDNESDAY, Aug. 22 (HealthDay ... frightening, traumatic memories go so deep and linger so ... rats shows that a powerful neurochemical called norepinephrine is ... but it also "imprints" an emotional fear tagged to ...
... weak or unsubstantiated, review finds , TUESDAY, Aug. 21 (HealthDay ... disease often lack proper documentation or validation, experts report in ... American Medical Association . , A team of researchers in ... They found that 286 (66.2 percent) of these claims were ...
... Fried, baked food compound poses no threat, major study finds ... be little or no link between breast cancer and acrylamide, ... to the largest epidemiological study on the subject conducted to ... acrylamide in the diet does not appear to be an ...
... in Taiwan has shown that an 800-year-old formula, Four-Agents ... pain after three cycles of treatment; however, a beneficial ... dosage regimen and treatment length used in this study ... published in the August 15 issue of the online, ...
... A computer bug infected Web gamers, with ominous results, ... Online role-playing games could provide insight into how infectious ... the real world, American researchers report. , A programming ... ("corrupted blood") among virtual characters in the popular online ...
Cached Medicine News:Health News:Melanoma Diagnosis Often Delayed for Rural Poor 2Health News:Study Probes Roots of Fearful Memories 2Health News:Gene Studies of Male-Female Differences Often Flawed 2Health News:Acrylamide Won't Raise Breast Cancer Risk 2Health News:Acrylamide Won't Raise Breast Cancer Risk 3Health News:Acrylamide Won't Raise Breast Cancer Risk 4Health News:Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea? 2Health News:Online 'Epidemic' Gives Clues to Bird Flu Spread 2
... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... explanation of foldable intraocular lenses. The instrument ... placed under the implant and divides the ... helps support both halves of the lens ... in the anterior chamber is avoided. The ...
Medicine Products: